Bayer HealthCare Pharmaceuticals Inc.

Industry / private company


Location: Whippany, NJ, United States (USA) (US) US

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial (2026) Vaduganathan M, Green JB, Heerspink HJ, Kim SG, Mann JF, McGill JB, Mottl A, et al. Journal article Real-world use of androgen-deprivation therapy intensification for metastatic hormone-sensitive prostate cancer: a systematic review (2024) Raval AD, Chen S, Littleton N, Constantinovici N, Goebell P Journal article, Review article LACK OF CONCORDANCE BETWEEN REAL-WORLD TREATMENT PATTERNS AND CLINICAL GUIDELINE RECOMMENDATIONS FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) PATIENTS (2022) Goebell P, Shah R, Raina R, Rege S, Chen S, Partridge J, Waldeck R Conference contribution